micronavigation ELN path item International Trials path item Basic information  · 

Basic information for International IITs

Created by: ihrig , generated 2009/03/20 , last changed: 2010/02/04

The collection will provide both general central (of European authorities and institutes) and country-specific information in terms of dossiers, formulars, lists/checklists, schedules, power-point-presentations and further more. The material is ordered by information in english (if available) first and secondly country-specific.The overall aim of the presented collection is to ease the process of initiating and conducting investigator-initiated-trials, resp. optimum-use-trials in the European LeukemiaNet.

Information

Impact assessment of the directive 2001/20/EC for stakeholders.
Deadline: January 08, 2010

The directive 2001/20/EC (Clinical-Trials-Directive on Good Clinical Practice) could be amended and the EC has started an impact assessment to evaluate the goals and functioning of the directive. Part of the assessment is a public consultation process, which was performed on behalf of the ELN and further EU projects and stakeholer groups. The commented paper presented here is clearly focusing on the poor situation of multinational therapy optimization trials (investigator-initiated trials) and highlighting necessary changes (see c).

You will find here the
a) link to the EC website with some general information on Directive General (DG) Enterprise and the directive and
b) direct link to the consultation paper
c) final statement of stakeholder (non-commercial sponsors) on behalf of the ELN.

The following link will also lead you to further commented papers. They will be made public available by DG enterprise and industry at their website.

2001/20/EC to comment
2001_20_EC_ConsultationPaper_Final-V2.pdf

Workshops of DG Research

Report on Investigator-driven clinical trials_ workshop Nov 09.pdf

EFGCP/ ICREL

EFGCP/ICREL is a project to evaluate the changes for clinical trials by EU directive

Denmark:

Regulatory Requirements: Overview

ECRIN-Report on Independent Review Board (IRB) and further requirements: Specifications for Denmark

France:

Regulatory requirements: Overview

ECRIN-Report on Independent Review Board (IRB) and further requirements: Specifications for France

Germany:

Regulatory requirements: Overview

ECRIN-Report on Independent Review Board (IRB) and further requirements: Specifications for Germany

Italy:

Regulatory requirements: Overview

ECRIN-Report on Independent Review Board (IRB) on further requirements: Specifications for Italy

Spain:

Regulatory requirements: Overview

ECRIN-Report on Independent Review Board (IRB) and further requirements: Specifications for Spain

Sweden:

Regulatory requirements: Overview

ECRIN-Report on Independent Review Board (IRB) and further requirements: Specifications for Sweden

Contact

Contact person for general content

If you like to

  • comment the general content of this part of the website,
  • suggest specific content to the European and/or national issues,
  • or name a national representative for your workpackage regarding the initiation and conduction of IITs
please send a mail to ihrig@med.uni-frankfurt.de.

Contact person for German issues

If you have any questions or suggestions, for example a specific document should be listed in the document collection, please contact ihrig@med.uni-frankfurt.de.

Miscellaneous

The administration of the website has been started in february 2008 and is still under construction.

 

Print this Document   Sitemap   Contact  
EUTOS
European Leukemia Trial Registry (ELTR) More ...
EUTOS
EUTOS for CML is a unique collaboration between the European LeukemiaNet and Novartis Oncology in Europe More ...


 
top